Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 72
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Curr Top Microbiol Immunol ; 315: 345-61, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17848071

RESUMO

Poxviruses are famous, or infamous, as agents of disease introduced into novel host species and between populations of the same species. This discussion concerns selected examples of poxviruses associated with vertebrate infections, i.e., the Chordopoxvirus subfamily of the family Poxviridae. Brief note is made of examples of members of the genera Leporipoxvirus and Parapoxvirus-like agents that have been recognized to have significant trans-host species impact. The remaining bulk of the discussion involves examples of members of the genus Orthopoxvirus, which are known to be (have been) involved with human disease, and their zoonotic origins.


Assuntos
Infecções por Poxviridae/transmissão , Infecções por Poxviridae/veterinária , Zoonoses , Animais , Surtos de Doenças/veterinária , Humanos , Poxviridae/patogenicidade , Poxviridae/fisiologia , Infecções por Poxviridae/epidemiologia , Especificidade da Espécie
2.
Rev Sci Tech ; 26(1): 203-15, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17633303

RESUMO

Emerging infectious diseases represent a grave threat to animal and human populations in terms of their impact on global health, agriculture and the economy. Vaccines developed for emerging infections in animals can protect animal health and prevent transmission of zoonotic diseases to humans. Examples in this paper illustrate how industry and public health can collaborate to develop a vaccine to prevent an emerging disease in horses (West Nile virus vaccine), how poultry vaccination can protect animals and prevent transmission to people (avian influenza vaccine), how regulatory changes can pave the way for vaccines that will control the carrier state in animals and thus prevent infection in humans (Bartonella henselae vaccine in cats) and how novel technologies could be applied to vaccinate wildlife reservoir species for rabies. Stemming from the realisation that zoonotic diseases are the predominant source of human emerging infectious diseases, it behoves academic, public health, and animal health agencies to consider creative constructive approaches to combat serious public health challenges. Vaccination of vector/reservoir species, when efficacious vaccines are available, offers significant advantages to combating zoonotic human disease.


Assuntos
Doenças dos Animais/prevenção & controle , Doenças dos Animais/transmissão , Controle de Doenças Transmissíveis/métodos , Doenças Transmissíveis Emergentes/veterinária , Saúde Pública , Vacinação/veterinária , Animais , Animais Domésticos , Animais Selvagens , Doenças Transmissíveis Emergentes/prevenção & controle , Reservatórios de Doenças/veterinária , Humanos , Zoonoses
3.
Arch Intern Med ; 156(21): 2491-5, 1996 Nov 25.
Artigo em Inglês | MEDLINE | ID: mdl-8944742

RESUMO

BACKGROUND: Bartonella quintana has recently been associated with homeless alcoholic men. Both B quintana and Bartonella henselae have been shown to be opportunistic pathogens of people with acquired immunodeficiency syndrome. The reservoirs and modes of transmission of these infections are incompletely known. OBJECTIVES: To examine serum samples that were taken from inner-city intravenous (IV) drug users for antibodies to Bartonella organisms to determine whether there is an urban transmission cycle for Bartonella species and to examine the demographic and behavioral characteristics of IV drug users to identify possible risk factors for infection with any of these agents. MATERIALS AND METHODS: A serologic survey was conducted, using a convenience sample of serum specimens collected during a study of IV drug use and human immunodeficiency virus infection among 630 inner-city residents in Baltimore, Md. A detailed questionnaire was administered at the initial collection of serum, and additional serum collections and questionnaire updates were made at 6-month intervals. The most recent available serum sample was tested for Bartonella antibody titer by using the indirect immunofluorescent antibody test with 3 antigens: Bartonella elizabethae, B henselae, and B quintana. Univariate and multivariate analyses of selected potential demographic and behavioral risk factors were conducted. RESULTS: Antibodies to Bartonella were highly prevalent in this group; more than 37% of all samples reacted with at least 1 antigen. Overall seroprevalence of antibodies to B elizabethae, B henselae, and B quintana was 33%, 11%, and 10%, respectively. Current IV drug use, frequency of injection, and seronegative human immunodeficiency virus status were significantly associated with Bartonella antibody presence, but these associations varied by analysis. There was a significant inverse association of antibody prevalence to B henselae and B quintana by using CD4+ cell counts among human immunodeficiency virus-seropositive individuals. CONCLUSIONS: Intravenous drug users have an elevated prevalence of antibodies to Bartonella organisms and may be at significant risk of becoming infected. Current IV drug use, high frequency of injection, and seronegative human immunodeficiency virus status are significant risk factors for an increased prevalence of Bartonella antibodies. The current natural histories of Bartonella species are rapidly changing, and mechanisms of transmission remain unknown.


Assuntos
Anticorpos Antibacterianos/sangue , Bartonella/imunologia , Abuso de Substâncias por Via Intravenosa/imunologia , Saúde da População Urbana , Adulto , Baltimore , Feminino , Soropositividade para HIV , Humanos , Modelos Logísticos , Masculino , Fatores de Risco , Abuso de Substâncias por Via Intravenosa/complicações
4.
Arch Intern Med ; 155(15): 1670-6, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-7542443

RESUMO

BACKGROUND: Bartonella henselae (formerly the genus Rochalimaea) has recently been isolated from patients with cat-scratch disease and their cats, and since September 1992 the Centers for Disease Control and Prevention has offered an indirect fluorescent antibody assay for Bartonella-specific antibody. METHODS: Physicians submitted serum samples from patients suspected of having cat-scratch disease or other Bartonella-associated illness and completed a questionnaire that recorded clinical information. Indirect fluorescent antibody assay was performed with the use of antigen derived from three Bartonella species: B henselae, Bartonella quintana, and Bartonella elizabethae. RESULTS: During 16 months, 3088 serum samples were received. The largest numbers of specimens and the highest percentages positive (titer, > or = 64) were observed in the fall and winter. Clinical histories of the first 600 patients for whom serum samples and completed information forms were received were examined in detail; seropositivity was significantly associated with cat contact, cat age of less than 1 year, cat scratch, presence of an inoculation papule, and regional adenopathy. Of 91 patients whose illness met a strict clinical definition of cat-scratch disease, 86 (95%) had titers of 64 or greater to either B henselae or B quintana. A fourfold rise or fall in titer was observed in 87 of 132 patients with paired serum samples. CONCLUSIONS: The indirect fluorescent antibody assay for Bartonella-specific antibody is sensitive for the diagnosis of cat-scratch disease. Redefinition of cat-scratch disease on the basis of cause and use of this assay as a diagnostic criterion is recommended.


Assuntos
Antígenos de Bactérias/sangue , Bartonella henselae/imunologia , Doença da Arranhadura de Gato/diagnóstico , Doença da Arranhadura de Gato/epidemiologia , Adolescente , Adulto , Doença da Arranhadura de Gato/imunologia , Criança , Diagnóstico Diferencial , Feminino , Imunofluorescência , Humanos , Masculino , Encaminhamento e Consulta , Sensibilidade e Especificidade , Estados Unidos/epidemiologia
5.
Microbes Infect ; 2(10): 1193-205, 2000 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11008109

RESUMO

Bartonella species were virtually unrecognized as modern pathogens of humans until the last decade. However, identification of Bartonella species as the agents of cat-scratch disease, bacillary angiomatosis, urban trench fever, and possible novel presentations of Carrion's disease has left little doubt of the emerging medical importance of this genus of organisms. The three primary human pathogenic bartonellae, Bartonella bacilliformis (Carrion's disease), B. henselae (cat-scratch disease), and B. quintana (trench fever), present noteworthy comparisons in the epidemiology, natural history, pathology, and host-microbe interaction that this review will briefly explore.


Assuntos
Infecções por Bartonella , Bartonella/patogenicidade , Zoonoses , Animais , Infecções por Bartonella/história , Infecções por Bartonella/microbiologia , Infecções por Bartonella/transmissão , Bartonella henselae/patogenicidade , Bartonella quintana/patogenicidade , Reservatórios de Doenças , História do Século XIX , História do Século XX , Humanos , Zoonoses/história , Zoonoses/microbiologia , Zoonoses/transmissão
6.
Pediatrics ; 96(6): 1137-42, 1995 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-7491236

RESUMO

OBJECTIVE: To assess the serologic response to Afipia and Bartonella, previously named Rochalimaea, in patients with cat scratch disease (CSD) and a healthy control group. DESIGN: Prospective, controlled trial. SETTING: Referral clinic and hospitalized patients in a university medical center. PARTICIPANTS: Eighty patients with CSD and 57 healthy control subjects of similar age. MAIN OUTCOME MEASURES: The immune responses to Afipia felis and Bartonella henselae were evaluated by a newly developed enzyme-linked immunosorbent assay (ELISA) in patients with CSD and healthy control subjects. Responses to B henselae were also measured by indirect fluorescent antibody (IFA) tests. Antibody levels to Bartonella quintana were measured by ELISA and IFA in a limited number of patients and control subjects. RESULTS: Of the 80 patients with clinical CSD, 56 had positive results of CSD skin tests. ELISA antibody levels to A felis did not differ between patients and control subjects, but immunoglobulin M (IgM) and IgG ELISA antibodies to B henselae and B quintana were significantly higher in patients than in control subjects. IFA responses to B henselae and B quintana were also significantly higher in patients than in control subjects. CONCLUSION: Patients with CSD had significant serologic responses to B henselae and B quintana but not to A felis, suggesting that the causative agent of CSD is antigenically related to the Bartonella genus and not to Afipia. The Bartonella IgM ELISA and IFA assay were both sensitive and specific and may be used to establish the diagnosis of CSD.


Assuntos
Antígenos de Bactérias/imunologia , Infecções por Bartonella/imunologia , Bartonella henselae/imunologia , Doença da Arranhadura de Gato/imunologia , Bactérias Gram-Negativas/imunologia , Infecções por Bactérias Gram-Negativas/imunologia , Adolescente , Adulto , Criança , Pré-Escolar , Ensaio de Imunoadsorção Enzimática/métodos , Ensaio de Imunoadsorção Enzimática/estatística & dados numéricos , Técnica Indireta de Fluorescência para Anticorpo/métodos , Técnica Indireta de Fluorescência para Anticorpo/estatística & dados numéricos , Humanos , Lactente , Estudos Prospectivos , Testes Cutâneos/métodos , Testes Cutâneos/estatística & dados numéricos , Estatísticas não Paramétricas
7.
Pediatr Infect Dis J ; 14(10): 866-9, 1995 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8584313

RESUMO

Between August 12 and September 27, 1994, five children in South Florida were hospitalized at a single hospital because of encephalopathy, presenting as status epilepticus, associated with cat-scratch disease (CSD). Diagnoses were confirmed by using an indirect fluorescent antibody test to detect antibody to Bartonella henselae, the causative agent of CSD. These cases represent the first cluster of CSD encephalopathy cases to be recognized in the United States. The patients lived within 7 miles of each other and all reported contact with pet or stray cats before developing regional lymphadenopathy and encephalopathy. All recovered fully. A high proportion of 124 cats from the local area were seropositive (62%) or bacteremic (22%). This study suggests that B. henselae can be associated with geographically focal clusters of CSD encephalitis and should be considered in the evaluation of children with acute encephalopathy.


Assuntos
Anticorpos Antibacterianos/análise , Bartonella henselae/imunologia , Doença da Arranhadura de Gato/complicações , Encefalite/etiologia , Animais , Animais Domésticos , Bartonella henselae/isolamento & purificação , Doença da Arranhadura de Gato/epidemiologia , Gatos , Criança , Pré-Escolar , Análise por Conglomerados , Cães , Encefalite/epidemiologia , Feminino , Florida/epidemiologia , Humanos , Incidência , Masculino
8.
Pediatr Infect Dis J ; 17(6): 447-52, 1998 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9655532

RESUMO

OBJECTIVE: To determine the efficacy of azithromycin in the treatment of patients with typical cat-scratch disease. DESIGN: Prospective, randomized, double blind, placebo-controlled clinical trial. SETTING: Large military medical center and its referring clinics. PATIENTS: Active duty military members and their dependents with laboratory-confirmed, clinically typical cat-scratch disease. INTERVENTION: Study participants assigned by randomization to treatment with oral azithromycin or placebo for 5 days. OUTCOME MEASURES: Lymph node volume was calculated using three dimensional ultrasonography at entry and at weekly intervals. The ultrasonographer was blinded to the treatment groups. Endpoint evaluations were predetermined as time in days to 80% resolution of the initial total lymph node volume. RESULTS: Demographic and clinical data showed that the azithromycin and placebo treatment groups were comparable at entry although the placebo group tended to be older. Eighty percent decrease of initial lymph node volume was documented in 7 of 14 azithromycin-treated patients compared with 1 of 15 placebo-treated controls during the first 30 days of observation (P = 0.026). After 30 days there was no significant difference in rate or degree of resolution between the two groups. CONCLUSIONS: Treatment of patients with typical cat-scratch disease with oral azithromycin for five days affords significant clinical benefit as measured by total decrease in lymph node volume within the first month of treatment.


Assuntos
Antibacterianos/uso terapêutico , Azitromicina/uso terapêutico , Bartonella henselae , Doença da Arranhadura de Gato/tratamento farmacológico , Adolescente , Adulto , Criança , Método Duplo-Cego , Feminino , Humanos , Modelos Logísticos , Linfonodos/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Ultrassonografia
9.
Am J Trop Med Hyg ; 57(5): 578-88, 1997 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9392599

RESUMO

A number of Bartonella isolates were obtained from seven species of rodents sampled from 12 geographic sites representing the major biotic communities of the southeastern United States. Bartonella were isolated from the blood of 42.2% of 279 tested rodents. The highest prevalence of infection typically occurred among the most commonly captured species in the rodent community. Four phylogenetic groups, uniting 14 genotypic variants of Bartonella, were identified by sequence analysis of the citrate synthase gene. The level of sequence homology between genotypic groups varied from 88.8% to 96.4%, and the degree of homology among variants within groups was > or = 97%. Cotton rats (Sigmodon hispidus) harbored up to three phylogenetic groups of Bartonella at a single site, and Bartonella of two phylogenetic groups were isolated from a single rodent. All the Bartonella isolated from three species of Peromyscus clustered in a single distinct phylogenetic group, suggesting some host specificity may occur. Mouse ascitic fluids produced in BALB/c mice inoculated with Bartonella of three phylogenetic groups demonstrated high indirect fluorescent antibody (IFA) titers to homologous antigens. However, use of eight Bartonella antigens in an IFA test with sera from 394 wild-caught rodents resulted in either little or extremely low titers of antibody.


Assuntos
Bartonella/isolamento & purificação , Roedores/microbiologia , Animais , Anticorpos Antibacterianos/sangue , Bacteriemia/veterinária , Bartonella/classificação , Genótipo , Camundongos , Filogenia , Ratos , Estados Unidos
10.
Am J Trop Med Hyg ; 61(2): 344-9, 1999 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10463692

RESUMO

During May 1998, we conducted a case-control study of 357 participants from 60 households during an outbreak of acute bartonellosis in the Urubamba Valley, Peru, a region not previously considered endemic for this disease. Blood and insect specimens were collected and environmental assessments were done. Case-patients (n = 22) were defined by fever, anemia, and intra-erythrocytic coccobacilli seen in thin smears. Most case-patients were children (median age = 6.5 years). Case-patients more frequently reported sand fly bites than individuals of neighboring households (odds ratio [OR] = 5.8, 95% confidence interval [CI] = 1.2-39.2), or members from randomly selected households > or = 5 km away (OR = 8.5, 95% CI = 1.7-57.9). Bartonella bacilliformis isolated from blood was confirmed by nucleotide sequencing (citrate synthase [g/tA], 338 basepairs). Using bacterial isolation (n = 141) as the standard, sensitivity, specificity, and positive predictive value of thin smears were 36%, 96%, and 44%, respectively. Patients with clinical syndromes compatible with bartonellosis should be treated with appropriate antibiotics regardless of thin-smear results.


Assuntos
Infecções por Bartonella/epidemiologia , Bartonella/isolamento & purificação , Surtos de Doenças , Adolescente , Adulto , Infecções por Bartonella/diagnóstico , Infecções por Bartonella/fisiopatologia , Estudos de Casos e Controles , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Peru/epidemiologia , Fatores de Risco
11.
Int J Antimicrob Agents ; 18(3): 217-22, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11673033

RESUMO

The in vitro susceptibilities of Bartonella and Rickettsia spp. to different concentrations of ciprofloxacin, levofloxacin, ofloxacin and sparfloxacin in Vero cell cultures, were determined by enumeration of immunofluorescent-stained bacilli. After incubation in a CO(2)-enriched atmosphere, inocula were replaced and tested with media containing 12 different concentrations of each antibiotic in replicate for each species and the monolayers were re-incubated. Growth status was determined by evaluation of immunofluorescent staining bacilli. Effective inhibitory antibiotic dilution endpoints were determined by counting Bartonella- and Rickettsia-specific fluorescent foci across a range of antibiotic dilutions with an epi-fluorescent microscope, and were compared with an antibiotic-negative control. Based upon the use of C(max):MIC and AUC:MIC data, levofloxacin exhibited activity against Bartonella elizabethae and B. quintana.


Assuntos
Anti-Infecciosos/farmacologia , Bartonella/efeitos dos fármacos , Rickettsia/efeitos dos fármacos , Animais , Chlorocebus aethiops , Contagem de Colônia Microbiana , Imunofluorescência , Fluoroquinolonas , Testes de Sensibilidade Microbiana , Células Vero/microbiologia
12.
Am J Vet Res ; 57(12): 1714-9, 1996 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8950424

RESUMO

OBJECTIVES: To elucidate kinetics of Bartonella henselae bacteremia and IgG response, evaluate antibiotic therapy, and investigate challenge exposure in cats. ANIMALS: Specific-pathogen-free cats. PROCEDURE: Cats were inoculated with B henselae or B quintana and monitored. Convalescent cats were challenge exposed with B henselae. Amoxicillin, enrofloxacin, erythromycin, and tetracycline HCl were evaluated for effect on B henselae bacteremia. RESULTS: Cats developed B henselae bacteremia within 1 week; bacteremia persisted for longer than 2 months before subsiding spontaneously. IgG antibody titer developed shortly after onset of bacteremia; antibody co-existed with bacteremia for several weeks and remained detectable after bacteremia subsided. Cats inoculated with B quintana remained abacteremic. On challenge exposure to B henselae, cats previously infected with B henselae remained abacteremic; cats previously inoculated with B quintana supported B henselae infection. Tetracycline HCl and erythromycin depressed B henselae bacteremia; however, duration of bacteremia remained similar to that in untreated cats. Obvious signs of illness were not observed. CONCLUSIONS: Long-duration, high-titer B henselae infections were highly reproducible in cats. Convalescent cats were immune to reinfection. B quintana-inoculated cats did not have evidence of infection and were susceptible to B henselae challenge exposure. Antibiotic therapy was incompletely efficacious in terminating cat bacteremia. CLINICAL RELEVANCE: A cat with an inapparent B henselae infection must provisionally be regarded as a possible reservoir for infection for a minimum of 2 to 3 months. Convalescent cats are resistant to reinfection. Usual antibiotic therapy was not completely efficacious. Measurement of IgG antibody can be used to detect past or current infection.


Assuntos
Angiomatose Bacilar/tratamento farmacológico , Angiomatose Bacilar/veterinária , Antibacterianos/uso terapêutico , Anti-Infecciosos , Bartonella henselae , Doenças do Gato , Fluoroquinolonas , Amoxicilina/uso terapêutico , Angiomatose Bacilar/fisiopatologia , Animais , Anticorpos Antibacterianos/sangue , Bacteriemia/tratamento farmacológico , Bacteriemia/fisiopatologia , Bacteriemia/veterinária , Bartonella henselae/isolamento & purificação , Gatos , Enrofloxacina , Eritromicina/uso terapêutico , Feminino , Imunoglobulina G/sangue , Quinolonas/uso terapêutico , Tetraciclina/uso terapêutico , Fatores de Tempo
13.
J Wildl Dis ; 35(2): 275-84, 1999 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10231754

RESUMO

The kinetics of infection and humoral immune response of laboratory-bred cotton rats (Sigmodon hispidus) challenged with three Bartonella spp. recovered from the blood of naturally infected cotton rats captured in Georgia (USA) are described. Bartonella spp. infection, as determined by bacteremia, occurred in all 18 cotton rats inoculated with live Bartonella of each species at either a low dose, 10(3) colony-forming units (CFU's), or high dose, 10(7) CFU. Cotton rats inoculated with lower doses of Bartonella spp. developed higher bacteremia that persisted for longer periods than in those inoculated with high doses. Peak bacteremia varied among Bartonella spp, ranging from 10(4) to 10(6) CFUs per 1.0 ml of blood. Antibody measured by immunofluorescence assays using species-specific antigens indicated more rapidly rising and higher antibody titers in cotton rats challenged with high doses vs. low doses and with inactivated bacteria vs. live bacteria. Each group of rats produced high IgG titers to the homologous challenge antigen; low or unmeasurable cross-reactivity was detected to heterologous Bartonella antigens. Exposure of cotton rats to a specific Bartonella sp. resulted in protection, as measured by detectable bacteremia, in eight of nine animals challenged with the same Bartonella sp. used initially; no evidence of resistance to secondary challenge with different Bartonella spp. was obtained. Cross-protection between Bartonella spp., isolated from the same rodent species, may not occur.


Assuntos
Bacteriemia/veterinária , Infecções por Bartonella/veterinária , Bartonella/fisiologia , Doenças dos Roedores/microbiologia , Sigmodontinae , Animais , Anticorpos Antibacterianos/biossíntese , Bacteriemia/imunologia , Bacteriemia/microbiologia , Bartonella/imunologia , Infecções por Bartonella/imunologia , Infecções por Bartonella/microbiologia , Modelos Animais de Doenças , Feminino , Masculino , Doenças dos Roedores/imunologia
14.
J Wildl Dis ; 34(2): 305-9, 1998 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9577777

RESUMO

Embryos and neonatal offspring of wild-captured cotton rats (Sigmodon hispidus) and white-footed mice (Peromyscus leucopus) were tested for the presence of Bartonella spp. Isolates of Bartonella spp. were obtained from 18 of 31 embryos and 7 of 19 neonates from bacteremic dams of the two species; no isolates were obtained from material from non-bacteremic dams. Sequence analysis demonstrated that the isolates from embryos and neonates matched the phylogenetic group of Bartonella spp. isolates obtained from the mother. No antibodies to homologous Bartonella spp. antigens were detected in maternal and neonatal blood or embryonic tissue. These findings suggest the possibility of vertical transmission of Bartonella spp. among natural rodent hosts.


Assuntos
Animais Recém-Nascidos/microbiologia , Infecções por Bartonella/veterinária , Bartonella/isolamento & purificação , Peromyscus/microbiologia , Doenças dos Roedores/microbiologia , Sigmodontinae/microbiologia , Animais , Anticorpos Antibacterianos/sangue , Bacteriemia/embriologia , Bacteriemia/microbiologia , Bacteriemia/veterinária , Bartonella/classificação , Bartonella/imunologia , Infecções por Bartonella/embriologia , Infecções por Bartonella/microbiologia , Infecções por Bartonella/transmissão , Citrato (si)-Sintase/genética , Contagem de Colônia Microbiana/veterinária , Embrião de Mamíferos/microbiologia , Feminino , Doenças Fetais/embriologia , Doenças Fetais/microbiologia , Doenças Fetais/veterinária , Transmissão Vertical de Doenças Infecciosas , Peromyscus/embriologia , Filogenia , Placenta/microbiologia , Gravidez , Complicações Infecciosas na Gravidez/microbiologia , Doenças dos Roedores/embriologia , Doenças dos Roedores/transmissão , Sigmodontinae/embriologia
15.
J Am Vet Med Assoc ; 204(11): 1775-8, 1994 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-8063598

RESUMO

Cats from several sources in Baltimore, Md, were tested for seropositivity to Rochalimaea henselae and R quintana. Co-infection with Toxoplasma gondii or feline immunodeficiency virus was assessed as a risk factor for infection with Rochalimaea spp. Of 592 cats tested, 87 (14.7%) were seropositive for one or both Rochalimaea spp, although titers to R henselae were significantly higher than those to R quintana. Prevalence of seropositivity increased significantly with cat age and weight and was associated with seropositivity to T gondii but was not associated with gender. Prevalence of seropositivity was similar (12.5 to 14.4%) among groups of cats with some history of human contact but was higher among feral cats (44.4%). Whether cats are reservoirs or mechanical vectors of Rochalimaea spp that can cause diseases in people is still uncertain, but these findings indicated widespread infection of cats and suggested possible modes of transmission for Rochalimaea spp among cats.


Assuntos
Anticorpos Antibacterianos/sangue , Doenças do Gato/epidemiologia , Infecções por Rickettsiaceae/veterinária , Rickettsieae/imunologia , Fatores Etários , Análise de Variância , Animais , Baltimore/epidemiologia , Gatos , Reservatórios de Doenças , Síndrome de Imunodeficiência Adquirida Felina/complicações , Feminino , Imunofluorescência/veterinária , Masculino , Análise Multivariada , Prevalência , Infecções por Rickettsiaceae/complicações , Infecções por Rickettsiaceae/epidemiologia , Fatores de Risco , Toxoplasmose Animal/complicações
16.
Acta Virol ; 36(1): 1-6, 1992 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-1350164

RESUMO

In order to facilitate the isolation and identification of spotted fever group (SFG) rickettsiae from their tick vectors, we used the centrifugation shell vial technique or traditional isolation procedures and genotypic identification using the restriction fragment length polymorphism analysis of polymerase chain amplified fragments. The presence of Rickettsia conorii both in Rhipicephalus sanguineus ticks collected in southern France, and in Rhipicephalus simus and Haemaphysalis leachi from Zimbabwe was demonstrated. This procedure seems to be of particular interest for studying the epidemiology and ecology of SFG rickettsiae.


Assuntos
Reação em Cadeia da Polimerase/métodos , Polimorfismo de Fragmento de Restrição , Rickettsia/isolamento & purificação , Animais , Centrifugação , Rickettsia/genética , Carrapatos/microbiologia , Células Vero
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA